학술논문
Does evidence from RCTs suggest: SGLT2 inhibitors could not reduce myocardial infarction and stroke?...Seo B, Su J, Song Y et al. Exploring heterogeneities of cardiovascular efficacy and effectiveness of SGLT2 inhibitors in patients with type 2 diabetes: an umbrella review of evidence from randomized clinical trials versus real-world observational studies. Eur J Clin Pharmacol. (2022)
Document Type
Academic Journal
Author
Source
Springer Nature (, ) Oct2022; v.78 n.10, 1703-1704. (2p)
Subject
Language
English
ISSN
0031-6970